Literature DB >> 25999280

Association Between TRAF6 Gene Polymorphisms and Susceptibility of Ischemic Stroke in Southern Chinese Han Population.

Li Su1, Ziwen Chen2, Yan Yan2, Baoyun Liang2, Juanjuan Xie2, Qing Chen2, Jinjing Tan2, Lian Gu3.   

Abstract

The tumor necrosis factor receptor-associated factor 6 (TRAF6) gene encodes a protein that acts downstream of the Toll-like receptor (TLR) pathway. TLRs activate inflammatory cascades and mediate inflammatory injury after cerebral ischemia. However, the role of TFAR6 gene polymorphisms in ischemic stroke (IS) remains unknown. This study aims to investigate the associations of TRAF6 gene polymorphisms with susceptibility to IS and IS-related quantitative traits in Southern Chinese Han population. A total of 816 IS cases and 816 age- and gender-matched controls were included. Two variants of the TRAF6 gene (rs5030411 and rs5030416) were genotyped using the Sequenom MassARRAY iPLEX platform. Our study showed that rs5030416 was significantly associated with increased susceptibility to IS in the additive model [ORadj 1.25(1.04-1.51), P adj = 0.019, P Bc = 0.038] and dominant model [ORadj 1.23(1.04-1.60), P adj = 0.021, P Bc = 0.042] after adjusting by age and sex and applying a Bonferroni correction. No significant association was found between rs5030411 and IS susceptibility (all P > 0.05). The haplotype rs5030416 (allele C)-rs5030411 (allele C) was significantly associated with IS susceptibility (P adj = 0.015). Moreover, a significant association of rs5030411 with TC levels in IS patients under the additive model [β 0.16(0.01-0.30), P adj = 0.034] and recessive model [β 0.45(0.12-0.78), P adj = 0.007] was observed after adjustment by age and sex. This association remained statistically significant under the recessive model (P Bc = 0.042) after Bonferroni correction. Our results suggest that TRAF6 gene polymorphisms may be involved in the pathogenesis of IS.

Entities:  

Keywords:  Ischemic stroke; Quantitative trait; TRAF6; rs5030411; rs5030416

Mesh:

Substances:

Year:  2015        PMID: 25999280     DOI: 10.1007/s12031-015-0580-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  43 in total

1.  A study of twins and stroke.

Authors:  L M Brass; J L Isaacsohn; K R Merikangas; C D Robinette
Journal:  Stroke       Date:  1992-02       Impact factor: 7.914

2.  Identification of TLR downstream pathways in stroke patients.

Authors:  Dean Wu; Yuan-Chii G Lee; Hsing-Cheng Liu; Rey-Yue Yuan; Hung-Yi Chiou; Chia-Hsiu Hung; Chaur-Jong Hu
Journal:  Clin Biochem       Date:  2013-05-29       Impact factor: 3.281

Review 3.  Potential new risk factors for ischemic stroke: what is their potential?

Authors:  Graeme J Hankey
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

4.  Infarcts of undetermined cause: the NINCDS Stroke Data Bank.

Authors:  R L Sacco; J H Ellenberg; J P Mohr; T K Tatemichi; D B Hier; T R Price; P A Wolf
Journal:  Ann Neurol       Date:  1989-04       Impact factor: 10.422

Review 5.  Tumor necrosis factor receptor-associated factors (TRAFs).

Authors:  J R Bradley; J S Pober
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

Review 6.  Current status of stroke epidemiology in Greece: a panorama.

Authors:  Angelo V Vasiliadis; Milorad Zikić
Journal:  Neurol Neurochir Pol       Date:  2014-11-13       Impact factor: 1.621

Review 7.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.

Authors:  Valery L Feigin; Carlene M M Lawes; Derrick A Bennett; Craig S Anderson
Journal:  Lancet Neurol       Date:  2003-01       Impact factor: 44.182

8.  Up-regulated tumor necrosis factor-associated factor 6 level is correlated with apoptosis in the rat cerebral ischemia and reperfusion.

Authors:  Ping Yuan; Zhiqiang Liu; Minghua Liu; Juan Huang; Xiaogang Li; Xiangyu Zhou
Journal:  Neurol Sci       Date:  2012-09-22       Impact factor: 3.307

Review 9.  Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches.

Authors:  Steve E Humphries; Laleh Morgan
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

10.  The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6).

Authors:  M Muzio; G Natoli; S Saccani; M Levrero; A Mantovani
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  2 in total

Review 1.  Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.

Authors:  Muhammad Abdullah; Jessica M Berthiaume; Monte S Willis
Journal:  Transl Res       Date:  2017-11-07       Impact factor: 7.012

2.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.